MEMPHIS, Tenn.--(BUSINESS WIRE)--Mar. 7, 2017--
GTx, Inc. (NASDAQ: GTXI) today announced that the timing for its fourth
quarter and full year 2016 financial results press release will be
Wednesday, March 15, 2017, prior to the opening of the U.S. stock
markets. The Company is not planning to host a conference call or
webcast on that date, but will continue to provide periodic updates on
clinical trial results and other material company developments as
appropriate throughout the remainder of the year.
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical
company dedicated to the discovery, development and commercialization of
small molecules for the treatment of cancer, including treatments for
breast and prostate cancer, and other serious medical conditions.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170307005307/en/
Source: GTx, Inc.
Lauren Crosby, 901-271-8622
Denise Powell, 510-703-9491